Neurofilament relates to white matter microstructure in older adults

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · see citing works

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · see citing works

Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data

Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C., Watkins, K., Ciccarelli, O., Cader, M., Matthews, P., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.024 · Cited by 6,035 · see citing works

Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250 · see citing works

The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease

Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,630 · see citing works

Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water

Song, S.-K., Sun, S.-W., Ramsbottom, M. J., Chang, C., Russell, J., & Cross, A. H. (2002) · NeuroImage · doi:10.1006/nimg.2002.1267 · Cited by 2,582 · see citing works

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · see citing works

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700 · see citing works

PET Imaging of Tau Deposition in the Aging Human Brain

Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214 · see citing works

Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease

Mattsson, N., Andreasson, U., Zetterberg, H., Blennow, K., & Initiative, F. T. A. D. N. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.6117 · Cited by 1,070 · see citing works

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.

D’Agostino, R. B., Wolf, P. A., Belanger, A. J., & Kannel, W. B. (1994) · Stroke · doi:10.1161/01.str.25.1.40 · Cited by 714 · see citing works

Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

Petzold, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.015 · Cited by 688 · see citing works

An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease

Jack, C. R., Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22628 · Cited by 602 · see citing works

Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice

Friede, R. L., & Samorajski, T. (1970) · The Anatomical Record · doi:10.1002/ar.1091670402 · Cited by 538 · see citing works

Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

Aisen, P. S. S., Petersen, R. C., Donohue, M., Gamst, A. C., Raman, R., Thomas, R. G., Walter, S., Trojanowski, J. Q., Shaw, L. M. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.006 · Cited by 516 · see citing works

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

Zetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J. Q., Portelius, E., Shaw, L. M., Weiner, M. W., Blennow, K., & Initiative, F. T. A. D. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3037 · Cited by 487 · see citing works

Hippocampal sclerosis can be reliably detected by magnetic resonance imaging

Jackson, G. D., Berkovic, S. F., Tress, B. M., Kalnins, R. M., Fabinyi, G., & Bladin, P. F. (1990) · Neurology · doi:10.1212/wnl.40.12.1869 · Cited by 435 · see citing works

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography

Palmqvist, S., Zetterberg, H., Blennow, K., Vestberg, S., Andreasson, U., Brooks, D. J., Owenius, R., Hägerström, D., Wollmer, P., Minthon, L., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1358 · Cited by 368 · see citing works

Neurochemical Aftermath of Amateur Boxing

Zetterberg, H., Hietala, M. A., Jonsson, M. A. G., Andreasen, N., Styrud, E., Karlsson, I., Edman, Å., Popa, C., Rasulzada, A., Wahlund, L., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1277 · Cited by 355 · see citing works

Effectiveness of regional DTI measures in distinguishing Alzheimer’s disease, MCI, and normal aging

Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.07.006 · Cited by 348 · see citing works

A Model for Diffusion in White Matter in the Brain

Sen, P. N., & Basser, P. J. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.063016 · Cited by 266 · see citing works

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263 · see citing works

Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer’s disease: A longitudinal retrospective study

Josephs, K. A., Dickson, D. W., Tosakulwong, N., Weigand, S. D., Murray, M. E., Petrucelli, L., Liesinger, A. M., Senjem, M. L., Spychalla, A. J., Knopman, D. S., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30284-3 · Cited by 252 · see citing works

Diffusion Tensor Imaging of Normal-Appearing White Matter in Mild Cognitive Impairment and Early Alzheimer Disease: Preliminary Evidence of Axonal Degeneration in the Temporal Lobe

Huang, J., Friedland, R. P., & Auchus, A. P. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0700 · Cited by 220 · see citing works

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS

Bergman, J., Dring, A. M., Zetterberg, H., Blennow, K., Norgren, N., Gilthorpe, J. D., Bergenheim, T. A., & Svenningsson, A. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000271 · Cited by 166 · see citing works

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS

Menke, R., Gray, E., Lu, C., Kühle, J., Talbot, K., Malaspina, A., & Turner, M. R. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.212 · Cited by 141 · see citing works

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light

Nimer, F. A., Thelin, E. P., Nyström, H., Dring, A. M., Svenningsson, A., Piehl, F., Nelson, D., & Bellander, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132177 · Cited by 136 · see citing works

Cerebrospinal Fluid Markers of Alzheimer’s Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer’s Disease

Melah, K. E., Lu, S. Y.-F., Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150897 · Cited by 109 · see citing works

Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18 F-AV1451 Positron Emission Tomography Imaging

Kim, Y. J., Park, S., Cho, H., Jang, Y. K., Lee, J. S., Jang, H., Kim, Y., Kim, K. W., Ryu, Y. H., Choi, J. Y., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0975 · Cited by 101 · see citing works

CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease

Bendlin, B. B., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., Willette, A. A., Okonkwo, O. C., Sodhi, A., Ries, M. L., Birdsill, A. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037720 · Cited by 91 · see citing works

Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury.

Marmarou, C. R., & Povlishock, J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.003 · Cited by 80 · see citing works

The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview

Jefferson, A. L., Gifford, K. A., Acosta, L. M. Y., Bell, S. P., Donahue, M. J., Davis, L. T., Gottlieb, J., Gupta, D. K., Hohman, T. J., Lane, E., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150914 · Cited by 67 · see citing works

Two‐level diagnostic classification using cerebrospinal fluid YKL‐40 in Alzheimer's disease

Baldacci, F., Toschi, N., Lista, S., Zetterberg, H., Blennow, K., Kilimann, I., Teipel, S., Cavedo, E., dos Santos, A. M., Epelbaum, S., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.021 · Cited by 53 · see citing works

Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments

Yates, D. M., Manser, C., Vos, K. J. D., Shaw, C. E., McLoughlin, D. M., & Miller, C. C. J. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.11.004 · Cited by 52 · see citing works

Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults

Racine, A. M., Merluzzi, A. P., Adluru, N., Norton, D., Koscik, R. L., Clark, L. R., Berman, S. E., Nicholas, C. R. N., Asthana, S., Alexander, A. L., et al. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9732-9 · Cited by 47 · see citing works

Longitudinal Alteration of Intrinsic Brain Activity in the Striatum in Mild Cognitive Impairment

Ren, P., Initiative, T. A. D. N., Lo, R. Y., Chapman, B. P., Mapstone, M. E., Porsteinsson, A. P., & Lin, F. V. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160368 · Cited by 39 · see citing works

Insulin-like growth factor binding protein-2 interactions with Alzheimer’s disease biomarkers

Initiative, A. D. N., Lane, E., Hohman, T. J., & Jefferson, A. L. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9636-0 · Cited by 38 · see citing works

Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity

Weekman, E. M., Sudduth, T. L., Caverly, C. N., Kopper, T. J., Phillips, O. W., Powell, D. K., & Wilcock, D. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1762-16.2016 · Cited by 37 · see citing works

Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes

Hohman, T. J., Samuels, L. R., Liu, D., Gifford, K. A., Mukherjee, S., Benson, E. M., Abel, T. W., Ruberg, F. L., & Jefferson, A. L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.021 · Cited by 28 · see citing works

Changes in mild cognitive impairment and its subtypes as seen on diffusion tensor imaging

Thillainadesan, S., Wen, W. X., Zhuang, L., Crawford, J., Kochan, N. A., Reppermund, S., Slavin, M. J., Trollor, J. N., Brodaty, H., & Sachdev, P. S. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000270 · Cited by 28 · see citing works

Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice

Sun, J., Zhou, H., Bai, F., Ren, Q., & Zhang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.8981 · Cited by 20 · see citing works

Neurofilaments as biomarkers in neurological disorders — towards clinical application

Khalil, M., Teunissen, C. E., Lehmann, S., Otto, M., Piehl, F., Ziemssen, T., Bittner, S., Sormani, M. P., Gattringer, T., Abu‐Rumeileh, S., et al. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00955-x · Cited by 484 · see citing works

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

Simrén, J., Leuzy, A., Karikari, T. K., Hye, A., Benedet, A. L., Lantero‐Rodriguez, J., Mattsson, N., Schöll, M., Mecocci, P., Vellas, B. J., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12283 · Cited by 334 · see citing works

Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies

Yuan, A., & Nixon, R. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.689938 · Cited by 290 · see citing works

Postoperative delirium is associated with increased plasma neurofilament light

Casey, C., Lindroth, H. L., Mohanty, R., Farahbakhsh, Z. Z., Ballweg, T., Twadell, S., Miller, S., Krause, B. M., Prabhakaran, V., Blennow, K., et al. (2019) · Brain · doi:10.1093/brain/awz354 · Cited by 178 · see citing works

Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study

Rajan, K. B., Aggarwal, N. T., McAninch, E. A., Weuve, J., Barnes, L. L., Wilson, R. S., DeCarli, C. S., & Evans, D. A. (2020) · Annals of Neurology · doi:10.1002/ana.25874 · Cited by 147 · see citing works

The multifaceted role of neurofilament light chain protein in non-primary neurological diseases

Abu‐Rumeileh, S., Abdelhak, A., Foschi, M., D’Anna, L., Russo, M., Steinacker, P., Kühle, J., Tumani, H., Blennow, K., & Otto, M. (2022) · Brain · doi:10.1093/brain/awac328 · Cited by 119 · see citing works

Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3

Zavaliangos-Petropulu, A., Nir, T. M., Thomopoulos, S. I., Reid, R. I., Bernstein, M. A., Borowski, B., Jack Jr., C. R., Weiner, M. W., Jahanshad, N., & Thompson, P. M. (2019) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2019.00002 · Cited by 101 · see citing works

CSF or Serum Neurofilament Light Added to α‐Synuclein Panel Discriminates Parkinson's From Controls

Oosterveld, L. P., Verberk, I. M. W., Majbour, N. K., El‐Agnaf, O. M. A., Weinstein, H. C., Berendse, H. W., Teunissen, C. E., & van de Berg, W. D. J. (2019) · Movement Disorders · doi:10.1002/mds.27897 · Cited by 93 · see citing works

Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls

Bavato, F., Barro, C., Schnider, L. K., Simrén, J., Zetterberg, H., Seifritz, E., & Quednow, B. B. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02524-6 · Cited by 92 · see citing works

Neurofilaments in disease: what do we know?

Gordon, B. A. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.001 · Cited by 82 · see citing works

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease

Andersson, E., Janelidze, S., Lampinen, B., Nilsson, M., Leuzy, A., Stomrud, E., Blennow, K., Zetterberg, H., & Hansson, O. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.018 · Cited by 79 · see citing works

Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: Results from the HABLE study

O’Bryant, S. E., Petersen, M. E., Hall, J. R., Johnson, L. A., Yaffe, K. S., Braskie, M. N., Toga, A. W., Rissman, R. A., & for the HABLE study team (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12404 · Cited by 79 · see citing works

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition

Osborn, K. E., Khan, O. A., Kresge, H. A., Bown, C. W., Liu, D., Moore, E. E., Gifford, K. A., Acosta, L. M. Y., Bell, S. P., Hohman, T. J., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.08.008 · Cited by 65 · see citing works

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease

Schultz, S. A., Strain, J. F., Adedokun, A., Wang, Q., Preische, O., Kühle, J., Flores, S. E., Keefe, S., Dincer, A., Ances, B. M., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104960 · Cited by 57 · see citing works

White Matter Disease and Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke

Mistry, E. A., Mistry, A. M., Mehta, T., Arora, N., Starosciak, A. K., Rosa, F. D. L. R. L., Siegler, J. E., Kasner, S. E., Chitale, R. V., Fusco, M. R., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6478 · Cited by 50 · see citing works

Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study

Rübsamen, N., Maceski, A. M., Leppert, D., Benkert, P., Kühle, J., Wiendl, H., Peters, A., Karch, A., & Berger, K. (2021) · BMC Medicine · doi:10.1186/s12916-021-01915-8 · Cited by 50 · see citing works

Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP Among Older Adults With and Without Cognitive Impairment

Asken, B., Vandevrede, L., Rojas, J. C., Fonseca, C., Staffaroni, A., Elahi, F., Lindbergh, C., Apple, A., You, M., Weiner-Light, S., et al. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721000813 · Cited by 38 · see citing works

High serum neurofilament associates with diffuse white matter damage in MS

Saraste, M., Bezukladova, S., Matilainen, M., Tuisku, J., Rissanen, E., Sucksdorff, M., Laaksonen, S., Vuorimaa, A., Kühle, J., Leppert, D., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000926 · Cited by 39 · see citing works

Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment

Jing, X., Wang, L., Song, M. L., Geng, H., Li, W., Huo, Y., Huang, A., Wang, X., & An, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-59530-5 · Cited by 35 · see citing works

Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer’s Disease Continuum in Young Urbanites Exposed to Air Pollution

Calderón‐Garcidueñas, L., Mukherjee, P. S., Waniek, K., Holzer, M., Chao, C., Thompson, C., Ramos, R. R., Calderón‐Garcidueñas, A. L., Franco-Lira, M., Reynoso-Robles, R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180853 · Cited by 32 · see citing works

Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates

Gallingani, C., Carbone, C., Tondelli, M., & Zamboni, G. (2024) · Brain Sciences · doi:10.3390/brainsci14030272 · Cited by 29 · see citing works

Altered static and dynamic voxel-mirrored homotopic connectivity in subacute stroke patients: a resting-state fMRI study

Chen, J., Sun, D., Shi, Y., Jin, W., Wang, Y., Xi, Q., & Ren, C. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00266-x · Cited by 29 · see citing works

Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers

Mielke, M. M., Przybelski, S. A., Lesnick, T. G., Kern, S., Zetterberg, H., Blennow, K., Knopman, D. S., Graff‐Radford, J., Petersen, R. C., Jack, C. R., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12239 · Cited by 30 · see citing works

Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer’s disease: results from ADNI

Nabizadeh, F., Balabandian, M., Rostami, M. R., Kankam, S. B., Ranjbaran, F., Pourhamzeh, M., & Initiative, A. D. N. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02095-y · Cited by 30 · see citing works

Whole-brain white matter abnormalities in human cocaine and heroin use disorders: association with craving, recency, and cumulative use

Gaudreault, P., King, S. G., Malaker, P., Nelly Alia-klein, A., & Goldstein, R. Z. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01833-y · Cited by 27 · see citing works

The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease

Walsh, P., Sudre, C. H., Fiford, C. M., Ryan, N. S., Lashley, T., Frost, C. D., & Barnes, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.008 · Cited by 28 · see citing works

White matter microstructure differences in individuals with dependence on cocaine, methamphetamine, and nicotine: Findings from the ENIGMA-Addiction working group

Ottino‐González, J., Uhlmann, A., Hahn, S., Cao, Z., Cupertino, R. B., Schwab, N., Allgaier, N. A., Nelly Alia-klein, A., Ekhtiari, H., Fouché, J., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109185 · Cited by 27 · see citing works

Longitudinal Changes in Blood Biomarkers of Clinical Alzheimer Disease in a Biracial Population Sample

Rajan, K. B., McAninch, E. A., Aggarwal, N. T., Barnes, L. L., Wilson, R. S., Weuve, J., DeCarli, C. S., & Evans, D. A. (2022) · Neurology · doi:10.1212/wnl.0000000000201289 · Cited by 25 · see citing works

Plasma lipids are associated with white matter microstructural changes and axonal degeneration

Iriondo, A., García‐Sebastián, M., Arrospide, A., de Arriba, M., Aurtenetxe, S., Barandiarán, M., Clerigué, M., Ecay‐Torres, M., Estanga, A., Gabilondo, A., et al. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00311-9 · Cited by 20 · see citing works

Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia

Hall, J. R., Johnson, L. A., Peterson, M. J., Julovich, D. A., Como, T., & O’Bryant, S. E. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210219105949 · Cited by 19 · see citing works

Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer’s Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness

Teipel, S. J., the DELCODE study group, Kuper-Smith, J. O., Bartels, C., Brosseron, F., Buchmann, M., Büerger, K., Catak, C., Janowitz, D., Dechent, P., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190446 · Cited by 18 · see citing works

Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia

Giuffrè, G. M., Quaranta, D., Costantini, E. M., Citro, S., Martellacci, N., Ninno, G. D., Vita, M. G., Guglielmi, V., Rossini, P. M., Calabresi, P., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106267 · Cited by 18 · see citing works

Elevated serum neurofilament light chain in children autism spectrum disorder: A case control study

He, W., Zhang, X.-J., Zhang, Y.-Q., & Zhang, W. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.06.012 · Cited by 14 · see citing works

Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span

Elmers, J., Colzato, L. S., Akgün, K., Ziemssen, T., & Beste, C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102037 · Cited by 14 · see citing works

Abnormal Dynamic Functional Networks in Subjective Cognitive Decline and Alzheimer's Disease

Wang, J., Wang, K., Liu, T., Wang, L., Suo, D., Xie, Y., Funahashi, S., Wu, J., & Pei, G. (2022) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2022.885126 · Cited by 13 · see citing works

Lower cardiac output is associated with neurodegeneration among older adults with normal cognition but not mild cognitive impairment

Moore, E. E., Liu, D., Bown, C. W., Kresge, H. A., Gupta, D. K., Pechman, K. R., Mendes, L. A., Davis, L. T., Gifford, K. A., Anderson, A. W., et al. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00398-0 · Cited by 12 · see citing works

Plasma Neurofilament Light Concentration Is Associated with Diffusion-Tensor MRI-Based Measures of Neurodegeneration in Early Parkinson’s Disease

Welton, T., Tan, Y. J., Saffari, S. E., Ng, S. Y., Chia, N. S. Y., Yong, A. C. W., Choi, X., Heng, D. L., Shih, Y., Hartono, S., et al. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223414 · Cited by 10 · see citing works

Path integration impairments reveal early cognitive changes in subjective cognitive decline

Segen, V., Kabir, M. R., Streck, A., Slavík, J., Glanz, W., Butryn, M., Newman, E. L., Tiganj, Z., & Wolbers, T. (2025) · Science Advances · doi:10.1126/sciadv.adw6404 · Cited by 10 · see citing works

White matter hyperintensity mediating gait disorders in iNPH patients via neurofilament light chain

Lu, Y., Yang, F., Deng, Y., Yan, A., Wei, W., & Fang, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1117675 · Cited by 10 · see citing works

Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences

Moore, E. E., Liu, D., Pechman, K. R., Acosta, L. M. Y., Bell, S. P., Davis, L. T., Blennow, K., Zetterberg, H., Landman, B. A., Schrag, M., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00139 · Cited by 11 · see citing works

Clinical Utility of the Pathogenesis-Related Proteins in Alzheimer’s Disease

Zhou, B., & Fukushima, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228661 · Cited by 9 · see citing works

Plasma NfL is associated with mild cognitive decline in patients with diabetes

Marutani, N., Akamine, S., Kanayama, D., Gotoh, S., Yanagida, K., Maruyama, R., Mori, K., Miyamoto, T., Adachi, H., Sakagami, Y., et al. (2022) · Psychogeriatrics · doi:10.1111/psyg.12819 · Cited by 9 · see citing works

Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer’s Disease Pathology

Osborn, K. E., Alverio, J., Dumitrescu, L. C., Pechman, K. R., Initiative, A. D. N., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., & Jefferson, A. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190077 · Cited by 9 · see citing works

Free-water: A promising structural biomarker for cognitive decline in aging and mild cognitive impairment

Sathe, A., Yang, Y., Schilling, K. G., Shashikumar, N., Moore, E. E., Dumitrescu, L. C., Pechman, K. R., Landman, B. A., Gifford, K. A., Hohman, T. J., et al. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00293 · Cited by 9 · see citing works

Neurological Biomarker Profiles in Royal Canadian Air Force (RCAF) Pilots and Aircrew

Rhind, S. G., Shiu, M. Y., Vartanian, O. A., Allen, S., Palmer, M., Ramirez, J., Gao, F., Scott, C. J. M., Homes, M. F., Gray, G. W., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14121296 · Cited by 6 · see citing works

Association of critically short telomeres with brain and blood markers of ageing and Alzheimer’s disease in older adults

Lehodey, A., Kaliman, P., Palix, C., de Florès, R., Touron, E., Turpin, A., Fauvel, S., Mézenge, F., Landeau, B., Chocat, A., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01635-0 · Cited by 6 · see citing works

Association of plasma neurofilament light chain with microstructural white matter changes in Down syndrome

Rosas, H. D., Mercaldo, N. D., Hasimoglu, Y. G., Petersen, M. E., Lewis, L. R., Lai, F., Powell, D. K., Dhungana, A., Demir, A., Keater, D., et al. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70023 · Cited by 5 · see citing works

Frontal White Matter Changes and Craving Recovery in Inpatients With Heroin Use Disorder

Gaudreault, P., King, S. G., Huang, Y., Ceceli, A. O., Kronberg, G., Nelly Alia-klein, A., & Goldstein, R. Z. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.51678 · Cited by 6 · see citing works

Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage

Moore, E. E., Khan, O. A., Shashikumar, N., Pechman, K. R., Liu, D., Bell, S. P., Nair, S., Terry, J. G., Gifford, K. A., Anderson, A. W., et al. (2021) · Stroke · doi:10.1161/strokeaha.121.034349 · Cited by 3 · see citing works

Generalized and specific whole-brain white matter abnormalities in human cocaine and heroin use disordersPreprint

Gaudreault, P., King, S. G., Malaker, P., Nelly Alia-klein, A., & Goldstein, R. Z. (2022) · medRxiv · doi:10.1101/2022.03.22.22272765 · Cited by 3 · see citing works

FRONTAL WHITE MATTER CHANGES INDICATE RECOVERY WITH INPATIENT TREATMENT IN HEROIN ADDICTIONPreprint

Gaudreault, P., King, S. G., Huang, Y., Ceceli, A. O., Kronberg, G., Nelly Alia-klein, A., & Goldstein, R. Z. (2024) · medRxiv · doi:10.1101/2024.06.10.24308719 · Cited by 3 · see citing works

Disrupted structural connectivity in ArcAβ mouse model of Aβ amyloidosis

Al-Amin, M. M., Grandjean, J., Klohs, J., & Kim, J. (2020) · doi:10.1101/2020.04.27.064634 · Cited by 2 · see citing works

Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage

Moore, E., Khan, O., Shashikumar, N., Pechman, K., Liu, D., Bell, S., Nair, S., Terry, J., Gifford, K., Anderson, A., et al. (2022) · UCL Discovery (University College London) · Cited by 2 · see citing works

Cellular Aging Signatures in the Plasma Proteome Record Human Health and DiseasePreprint

Ding, D. Y., Bot, V. A., Chen, K. S.-M., Groves, J. W., Pálovics, R., Masuda, D., Farinas, A., Oh, H. S., Wagner, V., Lu, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.704909 · Cited by 3 · see citing works

The fluid biomarkers of Alzheimer’s disease

Peng, Q., & Zhang, Z. (2021) · Brain Science Advances · doi:10.26599/bsa.2021.9050001 · Cited by 1 · see citing works

Association of Peak Width of Skeletonized Mean Diffusivity With Neurofilament Light Chain in Non‐Dementia Adults

Cui, R., Hu, H., Han, S., Liang, S., Liu, M., Gao, P., Chen, Y., Wang, Y., Guo, F., Xue, R., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70076 · Cited by 1 · see citing works

Lower cardiac output is a risk factor for faster cerebral atrophy over a 11‐year follow‐up period in APOE‐ ε4 carriers

Moore, E. E., Zhang, P., Khan, O. A., Liu, D., Gupta, D. K., Pechman, K. R., Gifford, K. A., Landman, B. A., Hohman, T. J., & Jefferson, A. L. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71598 · Cited by 1 · see citing works

Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease

Assefi, M., Sharafshah, A., Ashtari, A., Afshar, S., Moghtader, K. P., & Waheed, Y. (2024) · Neurology Letters · doi:10.61186/nl.3.2.1 · Cited by 1 · see citing works

Neuronal and glial dysfunction, white matter hyperintensities and cognition in ageing and Alzheimer’s disease

Lee, A. J., Howard, E., Saltiel, N. A., Hayes, J. P., & Hayes, S. M. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf068 · Cited by 1 · see citing works

Serum Neurofilament Light Chain and Inflammatory Cytokines as Biomarkers for Early Detection of Alzheimer's DiseasePreprint

Jing, X., Wang, L., Song, M. L., Geng, H., Li, W., Huo, Y., Huang, A., Wang, X., & An, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3828911/v1

Path integration impairments reveal early cognitive changes in Subjective Cognitive DeclinePreprint

Segen, V., Kabir, M. R., Streck, A., Slavik, J., Glanz, W., Butryn, M., Newman, E. L., Tiganj, Z., & Wolbers, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.17.638583

Additional file 2 of Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study

Rübsamen, N., Maceski, A., Leppert, D., Benkert, P., Kühle, J., Wiendl, H., Peters, A., Karch, A., & Berger, K. (2021) · Figshare · doi:10.6084/m9.figshare.14033662

Additional file 1 of Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study

Rübsamen, N., Maceski, A., Leppert, D., Benkert, P., Kühle, J., Wiendl, H., Peters, A., Karch, A., & Berger, K. (2021) · Figshare · doi:10.6084/m9.figshare.14033659

Synergistic effects of cerebral small vessel disease burden and plasma phosphorylated tau 181 on white matter microstructure and cognition in a Chinese cohort

Xu, J., Chen, H., Wang, Y., Hu, Z., Ke, Z., Huang, L., Mo, Y., Yang, D., Mao, C., Chen, Y., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag080 · Cited by 1 · see citing works

La place des biomarqueurs dans les essais de prévention de la maladie d'Alzheimer

Delrieu, J. (2021) · doi:10.70675/2b5f4719z01f9z4376z9dabzd5a185dc4d79

[O1–08–02]: ELEVATED CEREBROSPINAL FLUID NEUROFILAMENT LIGHT LEVELS ARE ASSOCIATED WITH COMPROMISED WHITE MATTER INTEGRITY AMONG OLDER ADULTS

Moore, E. E., Hohman, T. J., Badami, F. S., Pechman, K. R., Gordon, E. A., Acosta, L. M. Y., Bell, S. P., Babicz, M. A., Gifford, K. A., Anderson, A. W., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.07.077

Comparison of the prognostic value of cerebrospinal fluid and plasma neurofilament light in predicting longitudinal decline in white matter integrity among older adults

Moore, E. E., Shashikumar, N., Pechman, K. R., Bell, S. P., Gifford, K. A., Landman, B. A., Blennow, K., Zetterberg, H., Hohman, T. J., & Jefferson, A. L. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.054958

Neurofilament protein in cerebrospinal fluid: A marker of white matter changes

Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1242 · Cited by 209 · see citing works

Plasma neurofilament light is associated with white matter damage in Alzheimer's diseasePreprint

Nabizadeh, F., Balabandian, M., Rostami, M. R., Kankam, S. B., Ranjbaran, F., & Ranjbaran, F. (2020) · Research Square · doi:10.21203/rs.3.rs-115308/v2

Plasma neurofilament light and cerebrospinal fluid biomarkers are associated with white matter damage in Alzheimer's diseasePreprint

Nabizadeh, F., Balabandian, M., Rostami, M. R., & Kankam, S. B. (2020) · Research Square · doi:10.21203/rs.3.rs-115308/v1